Stocks and InvestingStocks and Investing
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022
Thu, February 24, 2022

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $41 on, Feb 24th, 2022


Published on 2024-10-27 19:49:52 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $47 to $41 on, Feb 24th, 2022.

Matthew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Drew Ranieri of "Morgan Stanley" Maintained at Sell with Decreased Target to $36 on, Friday, January 7th, 2022